Inhibitor Therapeutics, Inc. (INTI) › Shares OutstandingInhibitor Therapeutics, Inc. (INTI) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2012: 15.56M2013: 18.89M2014: 211.42M2015: 245.35M2016: 353.45M2017: 369.60M2018: 370.08M2019: 370.45M2020: 373.64M2021: 376.86M2022: 171.79M2023: 172.02M2024: 172.32M2025: 172.57M172.57M2012Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025172.57M+0.1%2024172.32M+0.2%2023172.02M+0.1%2022171.79M-54.4%2021376.86M+0.9%2020373.64M+0.9%2019370.45M+0.1%2018370.08M+0.1%2017369.60M+4.6%2016353.45M+44.1%2015245.35M+16.1%2014211.42M+1019.3%201318.89M+21.4%201215.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share